Rapid clearance of erythrodermic psoriasis with apremilast

BACKGROUND: Apremilast is a new immunomodulatory drug, a small molecule inhibitor of PDE4, which down-regulates the expression of multiple pro-inflammatory cytokines, such as tumor necrosis factor alpha, interleukin 17, interleukin 23. MAIN OBSERVATIONS: We describe a case of a 54-year-old man with...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Dermatol Case Rep
Prif Awduron: Papadavid, Evangelia, Kokkalis, Georgios, Polyderas, Georgios, Theodoropoulos, Konstantinos, Rigopoulos, Dimitrios
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Specjalisci Dermatolodzy 2017
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5776028/
https://ncbi.nlm.nih.gov/pubmed/29367871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3315/jdcr.2017.1246
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg